Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

EPIZYME, INC.

(EPZM)
OverzichtKoersenGrafiekenNieuwsRatingenAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Communiquťs de presse de la sociťtť EPIZYME, INC.
15/09EPIZYME : Announces Data from TAZVERIK (Tazemetostat) Clinical Programs to be Pr..
AQ
14/09EPIZYME : Announces Data from TAZVERIKģ (Tazemetostat) Clinical Programs to be P..
BU
23/08EPIZYME : Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)
AQ
20/08EPIZYME : Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BU
16/08EPIZYME : FIFTH AMENDMENT TO LEASE (Form 8-K)
PU
16/08EPIZYME, INC. : Entry into a Material Definitive Agreement, Financial Statements..
AQ
09/08EPIZYME : Management's Discussion and Analysis of Financial Condition and Result..
AQ
09/08EPIZYME : and HUTCHMED Announce Strategic Collaboration to Develop and Commercia..
AQ
09/08EPIZYME, INC. : Entry into a Material Definitive Agreement, Results of Operation..
AQ
09/08EPIZYME : Q2 Earnings Snapshot
AQ
09/08EPIZYME : Announces CEO Succession
BU
09/08EPIZYME : Reports Second Quarter 2021 Financial Results and Provides Business Up..
BU
03/08EPIZYME : Announces Date of Second Quarter 2021 Financial Results
BU
28/06EPIZYME, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
24/06EISAI : ANTICANCER AGENT 'TAZVERIK TABLETS 200mg' APPROVED IN JAPAN FOR EZH2 GEN..
AQ
16/06EPIZYME, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
16/06EPIZYME : Launches EZH2Now Testing Program with Quest Diagnostics for Relapsed o..
BU
25/05EPIZYME : to Participate in Jefferies Virtual Healthcare Conference
BU
12/05EPIZYME : Announces Preclinical and Clinical Data to be Presented in Oral and Po..
BU
06/05EPIZYME : Management's Discussion and Analysis of Financial Condition and Result..
AQ
06/05EPIZYME, INC. : Results of Operations and Financial Condition, Financial Stateme..
AQ
06/05EPIZYME : Q1 Earnings Snapshot
AQ
06/05EPIZYME : Provides Business Update and Reports First Quarter 2021 Financial Resu..
BU
29/04EPIZYME : Announces Date of First Quarter 2021 Financial Results
BU
09/03EPIZYME : Barclays Conference Presentation - March 2021
PU
03/03EPIZYME : Cowen Conference Presentation - March 2021
PU
02/03EPIZYME : Outlines Clinical Progress, TAZVERIK Development Strategy and Pipeline..
BU
24/02EPIZYME : Provides Business Update and Reports Fourth Quarter and Full Year 2020..
AQ
24/02EPIZYME : to Host Strategic Vision Call on March 2, 2021
BU
23/02EPIZYME : Results of Operations and Financial Condition, Financial Statements an..
AQ
23/02EPIZYME : Management's Discussion and Analysis of Financial Condition and Result..
AQ
23/02EPIZYME, INC. : Results of Operations and Financial Condition, Financial Stateme..
AQ
23/02EPIZYME : 4Q Earnings Snapshot
AQ
23/02EPIZYME : CORRECTING and REPLACING Epizyme Provides Business Update and Reports ..
BU
16/02EPIZYME : Announces Date of Fourth Quarter and Full Year 2020 Financial Results ..
BU
2020EPIZYME, INC. : Termination of a Material Definitive Agreement (form 8-K)
AQ
2020EPIZYME : to Participate in Jefferies Virtual London Healthcare Conference
BU
2020EPIZYME : Reports Business Progress and Third Quarter 2020 Financial Results
AQ
2020EPIZYME : Announces Expanded Loan Facility with Pharmakon Advisors for Additiona..
AQ
2020EPIZYME : 3Q Earnings Snapshot
AQ
2020EPIZYME, INC. : Results of Operations and Financial Condition, Financial Stateme..
AQ
2020EPIZYME : Reports Business Progress and Third Quarter 2020 Financial Results
BU
2020EPIZYME : Management's Discussion and Analysis of Financial Condition and Result..
AQ
2020EPIZYME : Announces Expanded Loan Facility with Pharmakon Advisors for Additiona..
BU
2020EPIZYME : Announces Date of Third Quarter 2020 Financial Results
AQ
2020EPIZYME : Announces Date of Third Quarter 2020 Financial Results
BU
2020EPIZYME : Announces Two Lancet Oncology Publications on TAZVERIK Phase 2 Data in..
AQ
2020EPIZYME : Announces Two Lancet Oncology Publications on TAZVERIKģ (tazemetostat)..
BU
2020EPIZYME : to Participate in Morgan Stanley 18th Annual Global Healthcare Confere..
BU
2020EPIZYME : Management's Discussion and Analysis of Financial Condition and Result..
AQ
2020EPIZYME, INC. : Results of Operations and Financial Condition, Financial Stateme..
AQ
2020EPIZYME : 2Q Earnings Snapshot
AQ
2020EPIZYME : Reports Business Progress and Second Quarter 2020 Financial Results
BU
2020EPIZYME : Announces Date of Second Quarter 2020 Financial Results and Participat..
BU
2020EISAI : Submits marketing authorization application in japan for anticancer agen..
AQ
2020EPIZYME : Announces U.S. FDA Accelerated Approval of TAZVERIK for Relapsed/Refra..
AQ
2020EPIZYME : †Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (t..
BU
2020EPIZYME, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
2020EPIZYME : to Present Data from Tazemetostat Clinical Program during the 2020 ASC..
BU
2020EPIZYME, INC. : Results of Operations and Financial Condition, Financial Stateme..
AQ
2020EPIZYME : Management's Discussion and Analysis of Financial Condition and Result..
AQ
2020EPIZYME : 1Q Earnings Snapshot
AQ
2020EPIZYME : Reports Business Progress and First Quarter 2020 Financial Results
BU
2020EPIZYME : Announces Date of First Quarter 2020 Financial Results
BU
2020EPIZYME : Appoints Jeffery Kutok, M.D., Ph.D., as Chief Scientific Officer
AQ
2020EPIZYME : Appoints Jeffery Kutok, M.D., Ph.D., as Chief Scientific Officer
BU
2020EPIZYME : Management's Discussion and Analysis of Financial Condition and Result..
AQ
2020EPIZYME : Corporate Presentation, Feb. 2020
PU
2020EPIZYME : 4Q Earnings Snapshot
AQ
2020EPIZYME, INC. : Results of Operations and Financial Condition, Financial Stateme..
AQ
2020EPIZYME : Provides Business Update and Reports Fourth Quarter and Full Year 2019..
BU
2020EPIZYME : Announces Date of Fourth Quarter and Full Year 2019 Results and Presen..
BU
2020EPIZYME : Announces FDA Acceptance of New Drug Application for Filing with Prior..
AQ
2020EPIZYME : Announces FDA Acceptance of New Drug Application for Filing with Prior..
BU
2020EPIZYME : Statement of changes in beneficial ownership of securities
PU
1  2  3  4Volgende
Volgende evenement op EPIZYME, INC.
03/11/21